APA (7th ed.) Citation

F, C., J, E., R, F., A, P., A, G., J, E., . . . RH, B. (2020). Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization around a Genotoxic Metabolite. ACS infectious diseases, 6(5), 1098. https://doi.org/10.1021/acsinfecdis.9b00493

Chicago Style (17th ed.) Citation

F, Cunningham, et al. "Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization Around a Genotoxic Metabolite." ACS Infectious Diseases 6, no. 5 (2020): 1098. https://doi.org/10.1021/acsinfecdis.9b00493.

MLA (9th ed.) Citation

F, Cunningham, et al. "Exploring the SAR of the β-Ketoacyl-ACP Synthase Inhibitor GSK3011724A and Optimization Around a Genotoxic Metabolite." ACS Infectious Diseases, vol. 6, no. 5, 2020, p. 1098, https://doi.org/10.1021/acsinfecdis.9b00493.